These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 22310580

  • 1. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
    Thammanichanond D, Athimang W, Paisooksantivatana K, Mongkolsuk T, Ingsathit A, Worawichawong S, Kitpoka P, Jirasiritham S, Kantachuvesiri S.
    Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007 Jan; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
    Ata P, Canbakan M, Kara M, Özel L, Ünal E, Titiz Mİ.
    Transplant Proc; 2012 Jan; 44(6):1652-5. PubMed ID: 22841237
    [Abstract] [Full Text] [Related]

  • 7. Kidney transplantation with positive complement-dependent lymphocytotoxicity crossmatch with negative flow crossmatching and Luminexx donor-specific antibodies.
    Kute VB, Vanikar AV, Gumber MR, Trivedi VB, Shah PR, Patel HV, Balwani MR, Modi PR, Trivedi HL.
    Ren Fail; 2013 Aug; 35(7):1027-30. PubMed ID: 23829775
    [Abstract] [Full Text] [Related]

  • 8. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy.
    Reinsmoen NL, Lai CH, Vo A, Cao K, Ong G, Naim M, Wang Q, Jordan SC.
    Transplantation; 2008 Sep 27; 86(6):820-5. PubMed ID: 18813107
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Improved graft survival in highly sensitized patients undergoing renal transplantation after the introduction of a clinically validated flow cytometry crossmatch.
    Limaye S, O'Kelly P, Harmon G, O'Neill D, Dorman AM, Walshe J, Donohoe J, Little D, Conlon PJ, Keogan MT.
    Transplantation; 2009 Apr 15; 87(7):1052-6. PubMed ID: 19352127
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.